Abstract
Laryngeal biopsies, contrary to biopsies from many other sites of the body, very often contain minute amounts of tumour tissue that may consist of morphologically undifferentiated tumour only. In haematoxylin- and eosin-stained sections, there may be no indicative features of what specific tumour entity that is present. In the larynx, particularly small round cell neoplasms, primary or metastatic, often cause a diagnostic dilemma and where an incorrect diagnosis can induce substantial clinical consequences for the patient (e.g., primary neuroendocrine carcinomas vs metastatic variants, certain sarcomas). If sufficient/representative material has been obtained, the application of immunohistochemistry and/or molecular techniques should in virtually every case reveal the true nature of the malignancy. In cases with sparse amount of material, and therefore a limited number of sections to be cut, a careful and thoughtful stepwise approach is necessary to ascertain a reliable diagnosis, or at least guide the clinician to the most likely diagnoses. With today’s advanced and widely available technology with an abundance of markers to discriminate different tumours, the use of the term “undifferentiated” should be largely unnecessary. In the exceptional, and indeed exceedingly rare cases, when a classification is not possible, even after repeat biopsy, we suggest that the laryngeal neoplasm is better termed “unclassified malignant neoplasm” rather than “undifferentiated malignant neoplasm”.
Similar content being viewed by others
References
Ferlito A, Friedmann I (1990) Poorly-differentiated laryngeal malignancies. ORL J Otorhinolaryngol Relat Spec 52:63–66
Ferlito A, Weiss LM, Rinaldo A, Carbone A, Devaney KO, MacMillan C, Barnes L (1997) Lymphoepithelial carcinoma of the larynx hypopharynx, and trachea. Ann Otol Rhinol Laryngol 106:437–344
Bishop JA, Gaulard P, Gibson M (2017) In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (eds) Lymphoepithelial carcinoma. In: WHO Classification of Head and Neck Tumours. IARC, Lyon, p 90
Wenig BM (2015) Lymphoepithelial-like carcinomas of the head and neck. Semin Diagn Pathol 32:74–86
Chan JY, Wong EW, Ng SK, Vlantis AC (2016) Non-nasopharyngeal head and neck lymphoepithelioma-like carcinoma in the United States: a population-based study. Head Neck 38(Suppl 1):E1294–E1300
MacMillan C, Kapadia SB, Finkelstein SD, Nalesnik MA, Barnes L (1996) Lymphoepithelial carcinoma of the larynx and hypopharynx: study of eight cases with relationship to Epstein-Barr virus and p53 gene alterations, and review of the literature. Hum Pathol 27:1172–1179
Coskun BU, Cinar U, Sener BM, Dadas (2005) Lymphoepithelial carcinoma of the larynx. Auris Nasus Larynx 32:189–193
Ibrahimov M, Yilmaz M, Celal MH, Mamanov M, Yollu U, Ozek H (2013) Lymphoepithelial carcinoma of the larynx. J Craniofac Surg 24:1049
French CA, Kutok JL, Faquin WC, Toretsky JA, Antonescu CR, Griffin CA, Nose V, Vargas SO, Moschovi M, Tzortzatou-Stathopoulou F, Miyoshi I, Perez-Atayde AR, Aster JC, Fletcher JA (2004) Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol 22:4135–4139
French CA (2012) Pathogenesis of NUT midline carcinoma. Annu Rev Pathol 7:247–265
French CA, Miyoshi I, Kubonishi I, Grier HE, Perez-Atayde AR, Fletcher JA (2003) BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res 63:304–307
French CA (2013) The importance of diagnosing NUT midline carcinoma. Head Neck Pathol 7:11–16
French CA, Rahman S, Walsh EM, Kühnle S, Grayson AR, Lemieux ME, Grunfeld N, Rubin BP, Antonescu CR, Zhang S, Venkatramani R, Dal Cin P, Howley PM (2014) NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism. Cancer Discov 4:928–941
Alekseyenko AA, Walsh EM, Wang X, Grayson AR, Hsi PT, Kharchenko PV, Kuroda MI, French CA (2015) The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains. Genes Dev 29:1507–1523
Hellquist H, French CA, Bishop JA, Coca-Pelaz A, Propst EJ, Paiva Correira A, Ngan BY, Grant R, Cipriani NA, Vokes D, Henrique R, Pardal F, Vizcaino JR, Rinaldo A, Ferlito A (2017) NUT midline carcinoma of the larynx: an international series and review of the literature. Histopathology 70:861–868
Haack H, Johnson LA, Fry CJ, Crosby K, Polakiewicz RD, Stelow EB, Hong SM, Schartz BE, Cameron MJ, Rubin MA, Chang MC, Aster JC, French CA (2009) Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol 33:984–991
Seethala RR, Hunt JL, Baloch ZW, Livolsi VA, Leon Barnes E (2007) Adenoid cystic carcinoma with high-grade transformation: a report of 11 cases and a review of the literature. Am J Surg Pathol 31:1683–1694
Hellquist H, Skálová A, Barnes L, Cardesa A, Thompson LD, Triantafyllou A, Williams MD, Devaney KO, Gnepp DR, Bishop JA, Wenig BM, Suárez C, Rodrigo JP, Coca-Pelaz A, Strojan P, Shah JP, Hamoir M, Bradley PJ, Silver CE, Slootweg PJ, Vander Poorten V, Teymoortash A, Medina JE, Robbins KT, Pitman KT, Kowalski LP, de Bree R, Mendenhall WM, Eloy JA, Takes RP, Rinaldo A, Ferlito A (2016) Cervical lymph node metastasis in high-grade transformation of head and neck adenoid cystic carcinoma: a collective international review. Adv Ther 33:357–368
Ferlito A, Friedmann I (1989) Review of neuroendocrine carcinomas of the larynx. Ann Otol Rhinol Laryngol 98:780–790
Ferlito A, Friedmann I (1991) Contribution of immunohistochemistry in the diagnosis of neuroendocrine neoplasms of the larynx. ORL J Otorhinolaryngol Relat Spec 53:235–244
Ferlito A, Silver CE, Bradford CR, Rinaldo A (2009) Neuroendocrine neoplasms of the larynx: an overview. Head Neck 31:1634–1646
Ferlito A, Rosai J (1991) Terminology and classification of neuroendocrine neoplasms of the larynx. ORL J Otorhinolaryngol Relat Spec 53:185–187
Mills SE (2002) Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas. Mod Pathol 15:264–278
Lewis JS Jr, Ferlito A, Gnepp DR, Rinaldo A, Devaney KO, Silver CE, Travis WD (2011) Terminology and classification of neuroendocrine neoplasms of the larynx. Laryngoscope 121:1187–1193
Xu B, Chetty R, Perez-Ordonez B (2014) Neuroendocrine neoplasms of the head and neck: some suggestions for the new WHO classification of head and neck tumors. Head Neck Pathol 8:24–32
Perez-Ordoñez B, Bishop JA, Gnepp DR, Hunt JL, Thompson LDR (2017) Neuroendocrine tumours. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (eds) WHO Classification of Head and Neck Tumours. IARC, Lyon, pp 95–98
Kimura N, Capella C, Gill A, Komminoth P, Lam AKY, Tischler AS et al (2017) Laryngeal paraganglioma. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (eds) WHO Classification of Head and Neck Tumours. IARC, Lyon, p 281
van der Laan TP, Plaat BE, van der Laan BF, Halmos GB (2015) Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: a meta-analysis of 436 reported cases. Head Neck 37:707–715
Hunt JL, Ferlito A, Hellquist H, Rinaldo A, Skálová A, Slootweg PJ, Willems SM, Cardesa A (2017) Differential diagnosis in neuroendocrine neoplasms of the larynx. Adv Anat Pathol 24:161–168
Wenig BM (1993) Malignant melanoma. In: Ferlito A (ed) Neoplasms of the larynx. Churchill-Livingstone, Edinburgh, pp 207–230
Wenig BM (1995) Laryngeal mucosal malignant melanoma. A clinicopathologic, immunohistochemical, and ultrastructural study of four patients and a review of the literature. Cancer 75:1568–1577
Wenig BM (2005) Mucosal malignant melanoma. In: Barnes L, Eveson JW, Reichert P, Sidransky D (eds) Pathology & Genetics Head and Neck Tumours. WHO Classification of Tumours. IARC, Lyon, pp 160–161
Durai R, Hashmi S (2006) Primary malignant melanoma of the epiglottis: a rare presentation. Ear Nose Throat J 85:274–277
Terada T, Saeki N, Toh K, Uwa N, Sagawa K, Mouri T, Sakagami M (2007) Primary malignant melanoma of the larynx: a case report and literature review. Auris Nasis Larynx 34:105–110
Aggarwal S, Kaushal V, Singla S, Sen R (2015) Primary glottic malignant melanoma of the larynx (PGMML): a very rare entity. BMJ Case Rep doi 2015:bcr2015211317. https://doi.org/10.1136/bcr-2015-211317
Blanchard A, Nguyen JB, Daroca P, Friedlander P, Lewin E, Vu J, Palacios E (2016) Rare primary mucosal melanoma of the larynx. Ear Nose Throat J 95:E28–E31
Zaghi S, Pouldar D, Lai C, Chhetri DK (2013) Subglottic presentation of a rare tumor: primary or metastatic? Primary mucosal melanoma of the subglottic larynx. JAMA Otolaryngol Head Neck Surg 139:739–740
Furman J, Murphy WM, Jelsma PF, Garzotto MG, Marsh RD (1996) Primary primitive neuroectodermal tumor of the kidney. Case report and review of the literature. Am J Clin Pathol 106:33–344
Wexler LH, DeLaney TF, Tsokos M, Avila N, Steinberg SM, Weaver-McClure L, Jacobson J, Jarosinski P, Hijazi YM, Balis FM, Horowitz ME (1996) Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphoamide for newly diagnosed Ewing’s sarcoma family of tumors. Cancer 78:901–911
Windfuhr JP (2004) Primitive neuroectodermal tumor of the head and neck: incidence, diagnosis, and management. Ann Otol Rhinol Laryngol 113:533–543
Hafezi S, Seethala RR, Stelow EB, Mills SE, Leong IT, MacDuff E, Perez-Ordoñez B, Weinreb I (2011) Ewing’s family of tumors of the sinonasal tract and maxillary bone. Head Neck Pathol 5:8–16
Abramowsky CR, Witt WJ (1983) Sarcoma of the larynx in a newborn. Cancer 51:1726–1730
Jones JE, McGill T (1995) Peripheral primitive neuroectodermal tumors of the head and neck. Arch Otolaryngol Head Neck Surg 121:1392–1395
Yang YS, Hong KH (2004) Extraskeletal Ewing’s sarcoma of the larynx. J Laryngol Otol 118:62–64
Wygoda A, Rutkowski T, Ponikiewska D, Hejduk B, Skladowski K (2013) Ewing’s sarcoma of the larynx. Effective treatment with organ preservation. Strahlenther Onkol 189:586–589
Lynch MC, Baker A, Drabick JJ, Williams N, Goldenberg D (2014) Extraskeletal Ewing’s sarcoma arising in the larynx. Head Neck Pathol 8:225–228
Ijichi K, Tsuzuki T, Adachi M, Murakami S (2016) A peripheral primitive neuroectodermal tumor in the larynx: a case report and literature review. Oncol Lett 11:1120–1124
Ginsberg JP, de Alava E, Ladanyi M, Wexler LH, Kovar H, Paulussen M, Zoubek A, Dockhorn-Dworniczak B, Juergens H, Wunder JS, Andrulis IL, Malik R, Sorensen PH, Womer RB, Barr FG (1999) EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing’s sarcoma. J Clin Oncol 17:1809–1814
Downing JR, Khandekar A, Shurtleff SA, Head DR, Parham DM, Webber BL, Pappo AS, Hulshof MG, Conn WP, Shapiro DN (1995) Multiplex RT-PCR assay for the differential diagnosis of alveolar rhabdomyosarcoma and Ewing’s sarcoma. Am J Pathol 146:626–634
Burchill SA, Wheeldon J, Cullinane C, Lewis IJ (1997) EWS-FLI1 fusion transcript identified in patients with typical neuroblastoma. Eur J Cancer 33:239–243
Scotlandi K, Chano T, Benini S, Serra M, Manara MC, Cerisano V, Picci P, Baldini N (2000) Identification of EWS/FLI-1 transcripts in giant-cell tumor of bone. Int J Cancer 87:328–335
Weidner N, Tjoe J (1994) Immunohistochemical profile of monoclonal antibody O13: antibody that recognizes glycoprotein p30/32MIC2 and is useful in diagnosing Ewing’s sarcoma and peripheral neuroepithelioma. Am J Surg Pathol 18:486–494
Folpe AL, Hill CE, Parham DM, O’Shea PA, Weiss SW (2000) Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing’s sarcoma/primitive neuroectodermal tumor. Am J Surg Pathol 24:1657–1662
Yoshida A, Sekine S, Tsuta K, Fukayama M, Furuta K, Tsuda H (2012) NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma. Am J Surg Pathol 36:993–999
Machado I, Yoshida A, López-Guerrero JA, Nieto MG, Navarro S, Picci P, Llombart-Bosch A (2017) Immunohistochemical analysis of NKX2.2, ETV4, and BCOR in a large series of genetically confirmed Ewing sarcoma family of tumors. Pathol Res Pract 213:1048–1053
Shibuya R, Matsuyama A, Nakamoto M, Shiba E, Kasai T, Hisaoka M (2014) The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma. Virchows Arch 465:599–605
Hung YP, Fletcher CDM, Hornick JL (2016) Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma. Mod Pathol 29:370–380
Zhang L, Yao M, Hisaoka M, Sasano H, Gao H (2016) Primary Ewing sarcoma/primitive neuroectodermal tumor in the adrenal gland. APMIS 124:624–629
McGuiston A, Bishop JA (2018) Usefulness of NKX2.2 immunohistochemistry for distinguishing Ewing sarcoma from other sinonasal small round blue cell tumors. Head Neck Pathol 12:89–94
Nicolai P, Ferlito A, Sasaki CT, Kirchner JA (1990) Laryngeal chondrosarcoma: incidence, pathology, biological behaviour, and treatment. Ann Otol Rhinol Laryngol 99:515–523
Chin OY, Dubal PM, Sheikh AB, Unsal AA, Park RC, Baredes S, Eloy JA (2017) Laryngeal chondrosarcoma: a systematic review of 592 cases. Laryngoscope 127:430–439
Bleiweiss IJ, Kaneko M (1988) Chondrosarcoma of the larynx with additional malignant mesenchymal component (dedifferentiated chondrosarcoma). Am J Surg Pathol 12:314–320
Brandwein M, Moore S, Som P, Biller H (1992) Laryngeal chondrosarcomas: a clinicopathologic study of 11 cases, including two “dedifferentiated” chondrosarcomas. Laryngoscope 102:858–867
Nakayama M, Brandenburg JH, Hafez GR (1993) Dedifferentiated chondrosarcoma of the larynx with regional and distant metastases. Ann Otol Rhinol Laryngol 102:785–791
Sakai O, Curtin HD, Faquin WC, Fabian RL (2000) Dedifferentiated chondrosarcoma of the larynx. AJNR Am J Neuroradiol 21:584–586
Garcia RE, Gannon FH, Thompson LD (2002) Dedifferentiated chondrosarcomas of the larynx: a report of two cases and review of the literature. Laryngoscope 112:1015–1018
Rinaggio J, Duffey D, McGuff HS (2004) Dedifferentiated chondrosarcoma of the larynx. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97:369–375
Casiraghi O, Martinez-Madrigal F, Pineda-Daboin K, Mamelle G, Resta L, Luna MA (2004) Chondroid tumors of the larynx: a clinicopathologic study of 19 cases, including two dedifferentiated chondrosarcomas. Ann Diagn Pathol 8:189–197
Purohit BS, Dulguerov P, Burkhardt K, Becker M (2014) Dedifferentiated laryngeal chondrosarcoma: combined morphologic and functional imaging with positron-emission tomography/magnetic resonance imaging. Laryngoscope 124:E274–E277
Fidai SS, Ginat DT, Langerman AJ, Cipriani NA (2016) Dedifferentiated chondrosarcoma of the larynx. Head Neck Pathol 10:345–348
Ferlito A, Rinaldo A, Marioni G (1999) Laryngeal malignant neoplasms in children and adolescents. Int J Pediatr Otorhinolaryngol 49:1–14
Hicks J, Flaitz C (2002) Rhabdomyosarcoma of the head and neck in children. Oral Oncol 38:450–459
Little DJ, Ballo MT, Zagars GK, Pisters PW, Patel SR, E-Naggar AK, Garden AS, Benjamin RS (2002) Adult rhabdomyosarcoma: outcome following multimodality treatment. Cancer 95:377–388
Shayah A, Agada FO, Karsai L, Stafford N (2007) Adult laryngeal rhabdomyosarcoma: report of a case and literature review. Ann Afr Med 6:190–191
Schrock A, Jakob M, Zhou H, Boota F (2007) Laryngeal pleomorphic rhabdomyosarcoma. Auris Nasus Larynx 34:553–556
Leventhal DD, Spiegel J, Keane W (2010) Laryngeal alveolar rhabdomyosarcoma involving the true vocal fold in an adult: case report. Ear Nose Throat J 89:E8
Pittore B, Fancello G, Cossu Rocca P, Ledda GP, Tore G (2010) Rhabdomyosarcoma: a rare laryngeal neoplastic entity. Acta Otorhinolaryngol Ital 30:52–57
Ohba S, Matsumoto F, Fujimaki M, Ito S, Yokoyama J, Ikeda K (2012) Embryonal rhabdomyosarcoma of the head and neck in an adult. Auris Nasus Larynx 39:326–328
Russell JO, Revenaugh PC, Budd GT, Greskovich J, Scharpf J (2015) Failed organ preservation strategy for adult laryngeal embryonal rhabdomyosarcoma. Am J Otolaryngol 36:277–279
Mungan S, Arslan S, Küçüktülü E, Ersöz S, Cobanoğlu B (2016) Pleomorphic rhabdomyosarcoma arising from the true vocal fold of larynx: report of a rare case and literature review. Case Rep Otolaryngol 2016:8135967. https://doi.org/10.1155/2016/8135967
Franchi A, Flucke U, Thompson LDR (2017) Rhabdomyosarcoma. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (eds) WHO Classification of Head and Neck Tumours. IARC, Lyon, pp 36–38
Roy S, Purgina B, Seethala RR (2013) Spindle cell carcinoma of the larynx with rhabdomyoblastic heterologous elements: a rare form of divergent differentiation. Head Neck Pathol 7:263–267
Bishop JA, Thompson LDR, Cardesa A, Barnes L, Lewis Jr JS, Triantafyllou A, Hellquist H, Stenson G, Hunt JL, Williams MD, Slootweg PJ, Devaney KO, Gnepp DR, Wenig BM, Rinaldo A, Ferlito A (2015) Rhabdomyoblastic differentiation in head and neck malignancies other than rhabdomyosarcoma. Head Neck Pathol 9:507–518
Powitzky R, Powitzky ES, Garcia R (2007) Liposarcoma of the larynx. Ann Otol Rhinol Laryngol 116:418–424
Zhu H, Sun J, Wei S, Wang D, Brandwein M (2017) Well-differentiated laryngeal/hypopharyngeal liposarcoma in the MDM2 era report of three cases and literature review. Head Neck Pathol 11:146–151
Binh MB, Sastre-Garau X, Guillou L, de Pinieux G, Terrier P, Lagacé R, Aurias A, Hostein I, Coindre JM (2005) MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol 29:1340–1347
Mariño-Enrique A, Fletcher CD, Dal Cin P, Hornick JL (2010) Dedifferentiated liposarcoma with “homologous” lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria. Am J Surg Pathol 34:1122–1131
Flucke U, Franchi A, Thompson LDR (2017) Liposarcoma. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (eds) WHO Classification of Head and Neck Tumours. IARC, Lyon, pp 100–101
Cowan ML, Thompson LD, Leon ME, Bishop JA (2016) Low-grade fibromyxoid sarcoma of the head and neck: a clinicopathologic series and review of the literature. Head Neck Pathol 10:161–166
Hanna E, Wanamaker J, Adelstein D, Tubbs R, Lavertue (1997) Extranodal lymphomas of the head and neck. A 20-year experience. Arch Otolaryngol Head Neck Surg 123:1318–1323
Horny HP, Kaiserling E (1995) Involvement of the larynx by hemopoietic neoplasms: an investigation of autopsy cases and review of the literature. Pathol Res Pract 191:130–138
Ferry JA, Chuang S-S (2017) Haematolymphoid tumours. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (eds) WHO Classification of Head and Neck Tumours. IARC, Lyon, p 104
Ferlito A, Caruso G, Recher G (1988) Secondary laryngeal tumors. Report of seven cases with review of the literature. Arch Otolaryngol Head Neck Surg 114:635–639
Kandukuri SR, Lin F, Gui L, Gong Y, Fan F, Chen L, Cai G, Liu H (2017) Application of immunohistochemistry in undifferentiated neoplasms: a practical approach. Arch Pathol Lab Med 141:1014–1032
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Full compliance with the ethical committees of the hospitals concerned.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
This article was written by members of the International Head and Neck Scientific Group (www.IHNSG.com).
Rights and permissions
About this article
Cite this article
Hellquist, H., Hunt, J.L., Cardesa, A. et al. Role of ancillary techniques in profiling unclassified laryngeal malignancies. Virchows Arch 472, 705–715 (2018). https://doi.org/10.1007/s00428-018-2348-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-018-2348-7